2461 related articles for article (PubMed ID: 7962038)
1. In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.
Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
J Cancer Res Clin Oncol; 1994; 120(11):631-5. PubMed ID: 7962038
[TBL] [Abstract][Full Text] [Related]
2. Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells.
Ohe Y; Podack ER; Olsen KJ; Miyahara Y; Ohira T; Miura K; Nishio K; Saijo N
Int J Cancer; 1993 Feb; 53(3):432-7. PubMed ID: 8428797
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNAs co-transfected subline.
Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
Gene Ther; 1994 Jul; 1(4):269-75. PubMed ID: 7584091
[TBL] [Abstract][Full Text] [Related]
4. The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.
Hollingsworth SJ; Darling D; Gäken J; Hirst W; Patel P; Kuiper M; Towner P; Humphreys S; Farzaneh F; Mufti GJ
Br J Cancer; 1996 Jul; 74(1):6-15. PubMed ID: 8679459
[TBL] [Abstract][Full Text] [Related]
5. Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejection.
Hara I; Nguyen H; Takechi Y; Gansbacher B; Chapman PB; Houghton AN
Int J Cancer; 1995 Apr; 61(2):253-60. PubMed ID: 7705956
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.
Kim TS; Cohen EP
Cancer Res; 1994 May; 54(10):2531-5. PubMed ID: 8168073
[TBL] [Abstract][Full Text] [Related]
7. Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2.
Cao X; Zhang W; Gu S; Yu Y; Tao Q; Ye T
J Cancer Res Clin Oncol; 1995; 121(12):721-8. PubMed ID: 7499443
[TBL] [Abstract][Full Text] [Related]
8. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
[TBL] [Abstract][Full Text] [Related]
9. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
[TBL] [Abstract][Full Text] [Related]
10. In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells.
Grangeon C; Cormary C; Douin-Echinard V; Favre G; Couderc B; Tilkin-Mariamé AF
Cancer Gene Ther; 2002 Mar; 9(3):282-8. PubMed ID: 11896445
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
Oniki S; Nagai H; Horikawa T; Furukawa J; Belladonna ML; Yoshimoto T; Hara I; Nishigori C
Cancer Res; 2006 Jun; 66(12):6395-404. PubMed ID: 16778218
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma.
Mackiewicz A; Wiznerowicz M; Roeb E; Nowak J; Pawlowski T; Baumann H; Heinrich PC; Rose-John S
Ann N Y Acad Sci; 1995 Jul; 762():361-73; discussion 373-4. PubMed ID: 7668537
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
[TBL] [Abstract][Full Text] [Related]
14. [Induction of tumor immunity by cytokine cDNA transfected Lewis lung carcinoma].
Ohira T; Ohe Y; Saijo N
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():48-51. PubMed ID: 1306238
[TBL] [Abstract][Full Text] [Related]
15. Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells.
Weiss JM; Shivakumar R; Feller S; Li LH; Hanson A; Fogler WE; Fratantoni JC; Liu LN
Cancer Gene Ther; 2004 May; 11(5):346-53. PubMed ID: 15031722
[TBL] [Abstract][Full Text] [Related]
16. Chemoattractive effect on the effector cells of the supernatants from melanoma cells transfected with the interleukin-2 (IL-2), IL-4 or IL-6 gene.
Cao X; Chen G; He L; Zhang W; Yu Y; Ye TX
J Cancer Res Clin Oncol; 1998; 124(2):88-92. PubMed ID: 9654191
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formation.
Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
J Invest Dermatol; 2002 Sep; 119(3):541-8. PubMed ID: 12230493
[TBL] [Abstract][Full Text] [Related]
18. Enhanced efficacy of combination of IL-2 gene and IL-6 gene-transfected tumor cells in the treatment of established metastatic tumors.
Cao X; Chen C; Zhang W; Tao Q; Yu Y; Ye T
Gene Ther; 1996 May; 3(5):421-6. PubMed ID: 9156803
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs.
Lim YS; Kang BY; Kim EJ; Kim SH; Hwang SY; Kim TS
Mol Cells; 1998 Oct; 8(5):629-36. PubMed ID: 9856353
[TBL] [Abstract][Full Text] [Related]
20. [The experimental study of expression of IL-2 cDNA in human bladder tumor cell and its biological behaviors].
Jin F; Yu M; Hui H
Zhonghua Wai Ke Za Zhi; 1996 Feb; 34(2):110-2. PubMed ID: 9388337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
